This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1995 Nov;1(11):1126-9.

doi: 10.1038/nm1195-1126.

Whether and when an AIDS vaccine?

Affiliations

PMID: 7584976
DOI: 10.1038/nm1195-1126

Whether and when an AIDS vaccine?

M R Hilleman. Nat Med. 1995 Nov.

. 1995 Nov;1(11):1126-9.

doi: 10.1038/nm1195-1126.

Author

Affiliation

¹ Merck Institute for Therapeutic Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

PMID: 7584976
DOI: 10.1038/nm1195-1126

No abstract available

PubMed Disclaimer

Similar articles

Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine.
Hilleman MR. Hilleman MR. Vaccine. 1995 Dec;13(18):1733-40. doi: 10.1016/0264-410x(95)00114-g. Vaccine. 1995. PMID: 8701586 Review.
Vaccine outlooks. After negative publicity and a series of setbacks over HIV/AIDS and influenza, the prospects for research on new vaccines are improving.
Hunter P. Hunter P. EMBO Rep. 2010 Oct;11(10):738-41. doi: 10.1038/embor.2010.136. EMBO Rep. 2010. PMID: 20877293 Free PMC article.
Rational design of vaccines for AIDS and influenza.
Nabel GJ. Nabel GJ. Trans Am Clin Climatol Assoc. 2012;123:9-15; discussion 15-6. Trans Am Clin Climatol Assoc. 2012. PMID: 23303965 Free PMC article.
Tim Tucker--Director of the South African AIDS Vaccine Initiative. Interviewed by Pam Das.
Tucker T. Tucker T. Lancet Infect Dis. 2003 Mar;3(3):173-5. doi: 10.1016/s1473-3099(03)00551-6. Lancet Infect Dis. 2003. PMID: 12614737 No abstract available.
Lymphocyte markers and infectious diseases.
Blumberg RS, Schooley RT. Blumberg RS, et al. Semin Hematol. 1985 Apr;22(2):81-114. Semin Hematol. 1985. PMID: 2988132 Review. No abstract available.

See all similar articles

Cited by

Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted.
Matteucci D, Pistello M, Mazzetti P, Giannecchini S, Del Mauro D, Lonetti I, Zaccaro L, Pollera C, Specter S, Bendinelli M. Matteucci D, et al. J Virol. 1997 Nov;71(11):8368-76. doi: 10.1128/JVI.71.11.8368-8376.1997. J Virol. 1997. PMID: 9343192 Free PMC article.
Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm?
Koff WC, Schultz AM. Koff WC, et al. J Clin Immunol. 1996 May;16(3):127-33. doi: 10.1007/BF01540910. J Clin Immunol. 1996. PMID: 8734355 Review.
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens.
Chiarantini L, Matteucci D, Pistello M, Mancini U, Mazzetti P, Massi C, Giannecchini S, Lonetti I, Magnani M, Bendinelli M. Chiarantini L, et al. Clin Diagn Lab Immunol. 1998 Mar;5(2):235-41. doi: 10.1128/CDLI.5.2.235-241.1998. Clin Diagn Lab Immunol. 1998. PMID: 9521149 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information